Cannabis 101 for Nurses
Cannabis 101 for Nurses
Order 100% Plagiarism Free Essay Now
Cannabis contains more than 500 compounds (Lafaye et al., 2017). Additionally, it is widely used and characterized by controversies. Even though cannabis is prohibited in the US, 29 states and the District of Columbia have legalized it. Currently, there is a wide range of cannabis-based cannabidiol (CBD) and tetrahydrocannabinol (THC) concentrations. Research shows that the potency ratio of THC to CBD could be the cause of the increasingly harmful effects of cannabis consumption (Lafaye et al., 2017). The essay will discuss how cannabis works in the body with respect to the endocannabinoid system (ECS) and endocannabinoid deficiency syndrome. The essay will also provide a discussion about routes for administering cannabis while focusing on its advantages and disadvantages.
Cannabis 101 for Nurses
Order 100% Plagiarism Free Essay Now
References
Brand, E. J., & Zhao, Z. (2017). Cannabis in Chinese medicine: are some traditional indications referenced in ancient literature related to cannabinoids?. Frontiers in Pharmacology, 8, 108. https://doi.10.3389/fphar.2017.00108
Gonçalves, J., Rosado, T., Soares, S., Simão, A. Y., Caramelo, D., Luís, Â., … & Duarte, A. P. (2019). Cannabis and its secondary metabolites: Their use as therapeutic drugs, toxicological aspects, and analytical determination. Medicines, 6(1), 31. https:// doi.10.3390/medicines6010031
I Khan, M., SobociŦ, A., M Czarnecka, A., Król, M., Botta, B., & Szczylik, C. (2016). The therapeutic aspects of the endocannabinoid system (ECS) for cancer and their development: From nature to laboratory. Current Pharmaceutical Design, 22(12), 1756- 1766. doi: 10.2174/1381612822666151211094901
Lafaye, G., Karila, L., Blecha, L., & Benyamina, A. (2017). Cannabis, cannabinoids, and health. Dialogues in Clinical Neuroscience, 19(3), 309. https://doi. 10.31887/DCNS.2017.19.3/glafaye
Peters, J., & Chien, J. (2018). Contemporary routes of cannabis consumption: A primer for clinicians. Journal of American Osteopathic Association, 118(2), 67-70. https://doi.10.7556/jaoa.2018.020
Schonhofen, P., Bristot, I. J., Crippa, J. A., Hallak, J. E. C., Zuardi, A. W., Parsons, R. B., & Klamt, F. (2018). Cannabinoid-based therapies and brain development: Potential harmful effect of early modulation of the endocannabinoid system. CNS Drugs, 32(8), 697-712. https://doi.org/10.1007/s40263-018-0550-4
Russo, E. B. (2016). Clinical endocannabinoid deficiency reconsidered: Current research supports the theory in migraine, fibromyalgia, irritable bowel, and other treatment-resistant syndromes. Cannabis and Cannabinoid Research, 1(1), 154-165. https://doi.10.1089/can.2016.0009